Paxlovid

US to pay Pfizer $2 billion for more course of its COVID-19 pill

Paxlovid has been shown to reduce hospitalizations and severe illness significantly.

New study:

COVID booster significantly delays end of infection

31% boosted people still contagious 10 days post-infection vs. 6% unvaccinated.

Dr. Anthony Fauci:

'America's doctor' feeling 'really poorly' after COVID rebound

Double-boostered & now on 2nd course of Paxlovid.

Pfizer sued for patent infringement in Paxlovid development

Pfizer accused of "willful and deliberate" violation, using other company's protease inhibitor.

New study:

Paxlovid 'of no significant benefit' to those under 65

Data suggests younger people using the Pfizer drug may have increased COVID mortality.

CDC warns of COVID rebound after Paxlovid treatment

CDC admits COVID can recur even in "patients who have been vaccinated and boosted."

Pfizer reporting strong demand for COVID pill

Pfizer CEO says company is seeing "very strong signs" of increasing demand for its COVID-19 pill.

Canada approves Pfizer's COVID-19 pill

Health Canada approves Pfizer’s drug, Paxlovid, as the first take-home treatment for COVID-19.

US to double order for Pfizer's COVID-19 pill

Biden announces government will double the order for Paxlovid, from 10 million to 20 million treatment courses.

Bahrain authorizes Pfizer's COVID-19 drug

Bahrain's health authorities authorize Paxlovid for emergency use in adults aged over 18.

1st shipment of Pfizer COVID pills arrive in Israel

Israel has purchased tens of thousands of doses of pill Pfizer says reduces risk of hospitalization and death from COVID by 90%.

Health Ministry approves Pfizer COVID-19 pill

Health Ministry and Pfizer have signed an agreement for Israel to purchase the drug, Paxlovid.

Report: Israel to purchase Pfizer's COVID-19 pill

TV report: Israel signs agreement to purchase tens of thousands of doses of Pfizer’s COVID-19 treatment pill.

FDA authorizes Pfizer's COVID-19 pill

Pfizer says the drug, administered in a pill called Paxlovid, reduces risk of hospitalization and death by up to 90%.